Canbex Therapeutics
London, England, United Kingdom
About Canbex Therapeutics
Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and other disorders. Spasticity is a debilitating and painful symptom that consists of involuntary spasms and stiffness of limbs and torso. The goal of the Canbex lead programme is to improve the lives of people with this serious and incurable disorder, and set a new standard in the treatment of spasticity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.0M
- Funding stage: M&A
- Last round: Grant (Sep 2013)
- Website: canbex.co.uk
- Phone: +4402075545872
Industries & Categories
Health Care, Medical, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/canbex-therapeutics-2527528 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.